Status | Study |
Recruiting |
Study Name: The Proteins of the Contact Activation System Condition: Factor XI Deficiency Factor XII Deficiency Date: 2016-05-25 Interventions: Other: Global Haemostasis assays |
No longer available |
Study Name: HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency Condition: Wound; Rupture, Surgery, Cesarean Section Postpartum Hemorrhage Date: 2012-10-03 Interventions: Biological: Hemoleven Replacement therapy Other Name |
Completed |
Study Name: A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery Condition: Hemophilia C Date: 2012-01-19 Interventions: Drug: recombinant factor VIIa single dose of 20ug/kg of recombinant factor VIIa along with tranexamic ac |